Wj. Kleijer et al., First-trimester diagnosis of late-infantile neuronal ceroid lipofuscinosis(LINCL) by tripeptidyl peptidase I assay and CLN2 mutation analysis, PRENAT DIAG, 21(2), 2001, pp. 99-101
Citations number
15
Categorie Soggetti
Reproductive Medicine","Medical Research Diagnosis & Treatment
Late-infantile neuronal ceroid lipofuscinosis (LINCL) is a progressive neur
odegenerative disorder caused by the deficiency of lysosomal tripeptidyl pe
ptidase I (TPP-I) encoded by the CLN2 gene. We report the first case of ear
ly prenatal diagnosis of LINCL by combined enzyme and mutation analysis. TP
P-I activity in chorionic villi (CV) was less than 2% of the mean normal co
ntrol level and g.1946A > G and 9.3670C > T mutations were demonstrated, as
in the two previously affected children. After termination of pregnancy, T
PP-I deficiency was confirmed in cultured CV cells and in the fetal skin fi
broblasts. The expression of unequivocal TPP-I deficiency in CV demonstrate
s that enzyme assay is a reliable option for prenatal diagnosis of LINCL. C
opyright (C) 2001 John Wiley & Sons, Ltd.